Moxigreat 0.5% Ophthalmic Solution is an antibiotic, used in the treatment of bacterial infections of the eye. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.

Moxigreat 0.5% Ophthalmic Solution is for external use only. Take it in the dose and duration as advised by your doctor. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid. Avoid skipping any doses and finish the full course of treatment even if you feel better.

It may cause eye discomfort, dry eyes and burning sensation in the eyes immediately following application. However, these side effects are temporary and usually subside on their own. Inform your doctor if they persist for a longer duration. It may cause short term blurring of vision when first used. Use caution before driving or using machines. Do not wear contact lenses while using it.

Uses of Moxigreat Ophthalmic Solution

Treatment of Bacterial eye infections

Benefits of Moxigreat Ophthalmic Solution

In Treatment of Bacterial eye infections

Moxigreat 0.5% Ophthalmic Solution is an antibiotic medicine. It works by stopping the growth of the bacteria that is causing the infection. It helps relieve symptoms such as pain, redness, itching or soreness caused due to eye infections. The dose and duration of treatment will be decided by your doctor based on your condition. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.

Side effects of Moxigreat Ophthalmic Solution

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Moxigreat

Burning sensation in eye
Eye discomfort
Dry eye

How to use Moxigreat Ophthalmic Solution

This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid.

How Moxigreat Ophthalmic Solution works

Moxigreat 0.5% Ophthalmic Solution is an antibiotic. It treats bacterial eye infections by preventing the bacteria from dividing and repairing. It does so stopping the action of a bacterial enzyme called DNA-gyrase.

Safety advice

Alcohol

No interaction found/established

Pregnancy

CONSULT YOUR DOCTOR

Moxigreat 0.5% Ophthalmic Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Moxigreat 0.5% Ophthalmic Solution is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

Moxigreat 0.5% Ophthalmic Solution may cause side effects which could affect your ability to drive.
Moxigreat 0.5% Ophthalmic Solution may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.

Kidney

No interaction found/established

Liver

No interaction found/established

What if you forget to take Moxigreat Ophthalmic Solution?

If you miss a dose of Moxigreat 0.5% Ophthalmic Solution, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Moxigreat 0.5% Ophthalmic Solution

₹96.9/Ophthalmic Solution

Vigamox Ophthalmic Solution

Alcon Laboratories

₹430.5/ophthalmic solution

331% costlier

Milflox 0.5% Eye Drop

Sun Pharmaceutical Industries Ltd

₹195/ophthalmic solution

95% costlier

Thomoxx Eye Drop

Syntho Pharmaceuticals Pvt Ltd

₹137.5/ophthalmic solution

38% costlier

Noxaplat Eye Drop

Ark Life Sciences Pvt Ltd

₹120/ophthalmic solution

20% costlier

Unimox Eye Drop

Univue Enterprises

₹170/ophthalmic solution

70% costlier

View all substitutes

Quick tips

You have been prescribed Moxigreat 0.5% Ophthalmic Solution for the treatment of bacterial infections of the eye.
Do not skip any doses and finish the full course of treatment even if you feel better.
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the medication.
Do not touch the tip to any surface, or to your eye, to avoid contamination.
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
It may cause short-term blurring of vision when first used. Use caution before driving or using machines.
Do not wear contact lenses until your infection clears up.
Make sure to use it within 4 weeks of opening the medication.

Fact Box

Chemical Class

Fluoroquinolone

Habit Forming

Therapeutic Class

OPHTHAL

Action Class

Quinolones/ Fluroquinolones

Patient concerns

Scar on face due to bacterial infections

Dr. Atul Jain

Dermatology

Pic is not clear, plz visit for proper opinion

I have a history of recurring yeast and bacterial vaginosis infections.

Dr. Sonu Balhara Ahlawat

Obstetrics and Gynaecology

Tab metrogyl 500 mg twice a day x 5 days and tab fluconazole 150 mg three doses alternate days

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 940-41.
Moxifloxacin. Camberley Surrey: Novartis Pharmaceuticals; 2009 [revised 19 Sep. 2018]. [Accessed 01 Apr. 2019] (online) Available from:
Moxifloxacin. Worth, Texas: Alcon Laboratories, Inc; 2003. [Accessed 01 Apr. 2019] (online) Available from:
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 01 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
CiplaMed. Moxifloxacin [Prescribing Information]. [Accessed 20 Feb. 2024] (online) Available from:
Moxifloxacin hydrochloride [EMC SmPC]. Dublin 4, Ireland: Novartis Ireland Limited; 2023. [Accessed 20 Feb. 2024] (online) Available from:

Marketer details

Name: Janus Biotech

Address: AO 105 B, Gurudwara Road, Sri Ganganagar-335001, Rajasthan, India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.